4.7 Review

β-lactam antibiotics: An overview from a medicinal chemistry perspective

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 208, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112829

Keywords

Penicillin; Cephalosporin; Monobactam; Carbapenem; Beta-lactamase; Beta-lactam

Funding

  1. CNPq
  2. CAPES [001]
  3. FAPERJ
  4. INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]

Ask authors/readers for more resources

beta-Lactam antibiotics are one of the most relevant drug classes of antibacterial agents worldwide. The discovery and the market of first beta-lactam antibiotic (Penicillin G) is a symbolic landmark of modern chemotherapy. Since then, several other beta-lactam antibiotics have been introduced in the therapy, revolutionizing the treatment of bacterial infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial resistance. Among the resistance mechanisms, the expression of beta-lactamase enzymes is one of the most studied and prevalent. The combined use of beta-lactamase inhibitors with broad spectrum activity beta-lactam antibiotics has been an effective strategy to circumvent the resistance issue. This review discusses, with a focus on structural aspects, the different classes of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams and penems) in light of their stability, sensitivity to beta-lactamases, mechanism of action and spectrum of antimicrobial activity. beta-Lactamase inhibitors (structurally correlated and non-correlated to the beta-lactam system) and their proposed inhibition mechanisms are also discussed. (c) 2020 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available